Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm
May 15, 2012
Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - UPDATE: Vermillion Posts Flat Q3 Revenues
November 13, 2012 / GenomeWeb Daily News - Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Vermillion to Raise up to $31.5M in Equity Financing
May 9, 2013 / GenomeWeb Daily News